Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Prednisolone in COPD Exacerbations
NCT00311961Phase 4Completed
- Sponsor
- Isala
- Start
- Jun 2001
- Primary completion
- Aug 2003
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Isala. Primary endpoint: Treatment failure. Started Jun 2001; status: completed.
02
Drugs
prednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00311961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311961.